The FTC is settling its case against a private equity portfolio company alleged to have been used to buy anesthesiology practices and raise prices in Texas. The development underscores ongoing antitrust scrutiny of private equity-backed rollups in healthcare. No financial terms of the settlement were provided in the article.
The FTC is settling its case against a private equity portfolio company alleged to have been used to buy anesthesiology practices and raise prices in Texas. The development underscores ongoing antitrust scrutiny of private equity-backed rollups in healthcare. No financial terms of the settlement were provided in the article.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.20
